EPISODE · Mar 9, 2026 · 42 MIN
Episode 9: Mark Mincy, Chief Commercial Officer at US-RX Care
from Digital Health Heavyweights · host Norm Volsky
In this episode of the Digital Health Heavyweights podcast, Norm Volsky interviews Mark Mincy, Chief Commercial Officer of USRX, to unpack the complex and often opaque world of pharmacy benefit management. They discuss fiduciary risks, conflicts of interest within traditional PBM models, and the structural incentives that drive up pharmacy costs for employers and employees. Mark shares his career journey in the pharmacy benefits space and explains why transparency, accountability, and independent fiduciary oversight are essential to meaningful reform. The conversation also explores specialty drug cost drivers, high-deductible health plans, legislative shifts, and how employers can take greater control of their pharmacy strategy without relying solely on legacy PBMs. Takeaways 💊 Pharmacy benefit management is one of the most misunderstood drivers of healthcare costs. ⚖️ Fiduciary risk in pharmacy benefits is growing and requires employer attention. 🏦 Traditional PBM models often contain structural conflicts of interest. 🔍 Transparency is critical for controlling pharmacy spending. 📈 Specialty drug costs are a major contributor to rising employer healthcare expenses. 🏢 Employers can reclaim control by reevaluating vendor relationships. 📜 Legislative reform may reshape the future of pharmacy benefit management. 🔄 Alternative PBM models are gaining traction as cost containment solutions. 💡 Evaluating pharmacy vendors requires deeper scrutiny beyond surface-level pricing guarantees. 🧘♂️ Maintaining personal wellbeing is crucial in a high-pressure healthcare industry. Chapters 00:00 Introduction to Pharmacy Benefit Management 03:02 Mark Mincy's Journey in Pharmacy Benefits 05:51 Understanding the Corruption in PBM Systems 08:40 The Role of Fiduciaries in Pharmacy Benefits 11:41 Challenges in the Current PBM Model 14:28 Legislative Recommendations for Pharmacy Benefits 17:15 Innovative Approaches at USRX Care 19:43 The Conflict of Interest in Pharmacy Benefits 22:01 Strategies for Managing Specialty Drug Costs 23:37 Taking Control of Pharmacy Benefits 25:50 The Impact of High-Deductible Health Plans 27:38 Future of Pharmacy Benefit Management 31:01 Evaluating Pharmacy Benefit Vendors 33:50 The Shift Towards Alternative PBMs 37:36 Navigating Change in Pharmacy Benefits 38:28 Maintaining Personal Well-being in a Stressful Industry 42:16 Outro Follow, connect and subscribe:LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcastYoutube: https://youtube.com/@DigitalHealthHeavyweightsInstagram: https://www.instagram.com/digitalhealthheavyweights/TikTok: https://www.tiktok.com/@heavyweightspodcast
What this episode covers
In this episode of the Digital Health Heavyweights podcast, Norm Volsky interviews Mark Mincy, Chief Commercial Officer of USRX, to unpack the complex and often opaque world of pharmacy benefit management. They discuss fiduciary risks, conflicts of interest within traditional PBM models, and the structural incentives that drive up pharmacy costs for employers and employees. Mark shares his career journey in the pharmacy benefits space and explains why transparency, accountability, and indepen...
NOW PLAYING
Episode 9: Mark Mincy, Chief Commercial Officer at US-RX Care
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m